Dr. Timothy Hughes Compares Imatinib to Nilotinib in Chronic Myeloid Leukemia OncLive 1:40 11 years ago 1 580 Далее Скачать
The efficacy of nilotinib treatment approaches in frontline CML VJHemOnc – Video Journal of Hematology & HemOnc 1:26 2 years ago 835 Далее Скачать
Dr. Donnellan on TFR in Patients With CML Treated With Nilotinib OncLive 1:50 8 years ago 985 Далее Скачать
Nilotinib Benefits Relapsed Patients With CML After Treatment Discontinuation Targeted Oncology 2:03 5 years ago 2 007 Далее Скачать
Jayshree Shah on the Safety and Efficacy of Nilotinib for Patients With CML OncLive 1:41 12 years ago 2 228 Далее Скачать
Dr Giuseppe Saglio Compares Efficacy, Safety of Nilotinib with Imatinib for CML Patients AJMCtv 1:28 10 years ago 709 Далее Скачать
Resistance to Targeted-TKI Treatment in Patients With CML Targeted Oncology 6:51 5 years ago 419 Далее Скачать
Starting first-line treatment, update on Imatinib. CML Support Group UK 19:12 5 years ago 1 407 Далее Скачать
Discontinuing treatment and predicting relapse in CML VJHemOnc – Video Journal of Hematology & HemOnc 4:03 6 years ago 1 317 Далее Скачать
Nilotinib Versus Imatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive CML-CP Oncology.TV 4:47 12 years ago 2 573 Далее Скачать
Comparing Frontline Therapies for the Treatment of Chronic Myeloid Leukemia Targeted Oncology 1:59 5 years ago 202 Далее Скачать
Dr. Pamela Crilley on Imatinib and Second Generation TKIs Targeted Oncology 1:43 12 years ago 421 Далее Скачать
Nilotinib for Myeloid Leukemia MDedge: news and insights for busy physicians 3:04 14 years ago 3 568 Далее Скачать
Summary of Cardiac Effects of NILOTINIB and IMATINIB in Patients Enrolled in ENESTND Trial Oncology.TV 3:54 13 years ago 963 Далее Скачать
CML as an Ideal Cancer for Targeted Therapy With TKI Targeted Oncology 7:32 5 years ago 374 Далее Скачать
